ID
44992
Descripción
Principal Investigator: Deborah Nickerson, PhD, Department of Genome Sciences, University of Washington, Seattle, WA, USA MeSH: Kabuki syndrome https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000295 The ultimate purpose of this research is to identify genes causing hereditary disorders. We are scaling a new approach to identify the candidate genes and gene mutations that underlie rare human Mendelian (a set of primary tenets relating to the transmission of hereditary characteristics from parent to child) diseases by using exome (protein coding segments of DNA) resequencing. The exome sequences of ten unrelated individuals with a diagnosis of Kabuki Syndrome (OMIM: 147920) were obtained by massively parallel DNA sequencing.
Link
https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000295
Palabras clave
Versiones (2)
- 23/6/22 23/6/22 - Dr. Christian Niklas
- 12/10/22 12/10/22 - Adrian Schulz
Titular de derechos de autor
Deborah Nickerson, PhD, Department of Genome Sciences, University of Washington, Seattle, WA, USA
Subido en
23 de junio de 2022
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
dbGaP phs000295 Next Generation Mendelian Genetics: Kabuki Syndrome
This subject consent data table contains subject IDs, consent group information, and subject aliases.
- StudyEvent: SEV1
- Eligibility Criteria
- This subject consent data table contains subject IDs, consent group information, and subject aliases.
- This subject sample mapping data table includes a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample aliases and sample use.
- This is a subject phenotype table of unrelated subjects who have been diagnosed with Kabuki Syndrome. This table contains measurements for the presence and absence of atrial and ventricular septic defects, aortic coarctation, bicuspid valves, dysrhythmia, spleen/liver/kidney abnormality and dysfunction, hearing loss, preauricular pits tags, cleft and high arched palate, hypotonia, and developmental delay.
- This sample attributes data table includes body site where sample was collected, analyte type, and tumor status.
Similar models
This subject consent data table contains subject IDs, consent group information, and subject aliases.
- StudyEvent: SEV1
- Eligibility Criteria
- This subject consent data table contains subject IDs, consent group information, and subject aliases.
- This subject sample mapping data table includes a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample aliases and sample use.
- This is a subject phenotype table of unrelated subjects who have been diagnosed with Kabuki Syndrome. This table contains measurements for the presence and absence of atrial and ventricular septic defects, aortic coarctation, bicuspid valves, dysrhythmia, spleen/liver/kidney abnormality and dysfunction, hearing loss, preauricular pits tags, cleft and high arched palate, hypotonia, and developmental delay.
- This sample attributes data table includes body site where sample was collected, analyte type, and tumor status.
C1257890 (UMLS CUI [1,2])
C0681850 (UMLS CUI [1,2])
C0449416 (UMLS CUI [1,2])
C0796004 (UMLS CUI [1,2])